-+ 0.00%
-+ 0.00%
-+ 0.00%

Dicot Pharma Wins Swedish Approval for LIB-01 Phase 2b Trial

PUBT·11/19/2026 11:50:00
Listen to the news
Dicot Pharma Wins Swedish Approval for LIB-01 Phase 2b Trial
  • Dicot Pharma received Swedish approval for its phase 2b trial of erectile dysfunction drug LIB-01, its first EU clearance.
  • EU dosing can begin once the US trial’s first part concludes, expected in the first quarter of 2027.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dicot Pharma AB published the original content used to generate this news brief on November 19, 2026, and is solely responsible for the information contained therein.